Different Culture Methods Lead to Differences in Glycosylation of a Murine IgG Monoclonal Antibody
Overview
Authors
Affiliations
A monoclonal IgG-1 was produced by culture of a murine hybridoma (3.8.6) by three different methods, namely culture in ascites, in serum-free media and in serum-supplemented media. IgG-1 was purified to homogeneity (as judged by SDS/PAGE under reducing conditions) from each medium by ion-exchange chromatography and h.p.l.c. Protein A chromatography. Oligosaccharides were released from each IgG-1 preparation by hydrazinolysis and radiolabelled by reduction with alkaline sodium borotritide, and 'profile' analysis of the radiolabelled oligosaccharide alditols was performed by a combination of paper electrophoresis and gel-filtration chromatography. This analysis indicated clear and reproducible differences in the glycosylation patterns of the three IgG-1 preparations. Sequential exoglycosidase analysis of individual oligosaccharides derived from each IgG-1 preparation was used to define these differences. Ascites-derived material differed from serum-free-culture-derived material only with respect to the content of sialic acid. IgG-1 derived from culture in serum-containing media had an intermediate sialic acid content and a lower incidence of outer-arm galactosylation than the other two preparations. These differences in glycosylation could not be induced in any IgG-1 preparation by incubating purified IgG-1 with ascites or culture medium. It is concluded that the glycosylation pattern of a secreted monoclonal IgG is dependent on the culture method employed to obtain it.
Modulating antibody effector functions by Fc glycoengineering.
Garcia-Alija M, Van Moer B, Sastre D, Azzam T, Du J, Trastoy B Biotechnol Adv. 2023; 67:108201.
PMID: 37336296 PMC: 11027751. DOI: 10.1016/j.biotechadv.2023.108201.
Dickey T, Gupta R, McAleese H, Ouahes T, Orr-Gonzalez S, Ma R NPJ Vaccines. 2023; 8(1):20.
PMID: 36808125 PMC: 9938515. DOI: 10.1038/s41541-023-00619-9.
van der Horst H, Nijhof I, Mutis T, Chamuleau M Cancers (Basel). 2020; 12(10).
PMID: 33086644 PMC: 7603375. DOI: 10.3390/cancers12103041.
Synthetic Glycobiology: Parts, Systems, and Applications.
Kightlinger W, Warfel K, DeLisa M, Jewett M ACS Synth Biol. 2020; 9(7):1534-1562.
PMID: 32526139 PMC: 7372563. DOI: 10.1021/acssynbio.0c00210.
Yamano N, Omasa T Cytotechnology. 2018; 70(6):1697-1706.
PMID: 30069612 PMC: 6269352. DOI: 10.1007/s10616-018-0243-3.